Literature DB >> 19535892

Testosterone acts as an efficacious vasodilator in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations.

K O Rowell1, J Hall, P J Pugh, T H Jones, K S Channer, R D Jones.   

Abstract

BACKGROUND: Testosterone is recognized to elicit vasodilatation in numerous vascular beds, however to date no study has investigated whether testosterone has this effect in the human pulmonary vasculature. AIM: To determine whether isolated human pulmonary arteries and veins dilate in response to testosterone and whether the response differs in relation to gender, endothelial function or location with the pulmonary vasculature.
METHODS: Intralobar pulmonary arteries [no.=44, diameter =581 (349) microm] and veins [no.=27, diameter =573 (302) microm] were dissected from lobectomy samples obtained from male and female patients [no.=40, age =69 (8) yr]. Vessels were mounted in an automated wire myograph, bathed in physiological saline at 37 C and pH 7.4, and loaded to their in vivo pressure. Vessels were preconstricted with noradrenaline (10 microM) and exposed to acetylcholine (1 microM) to assess endothelial function, washed and then preconstricted with potassium chloride (1-100 mM) followed by either cumulative concentrations of testosterone (1 nM-100 microM) or ethanol vehicle (<0.1%).
RESULTS: Significant marked vasodilatation was seen in all vessels, irrespective of size, gender and endothelial function at micromolar concentrations. Testosterone triggered significant vasodilatation at concentrations > or = 10 nM in pulmonary arteries obtained from males, a response which was not observed in vessels from females. The maximal response at 100 microM was also significantly greater in male pulmonary arteries. Significant vasodilatation was only observed at physiological (nM) concentrations in pulmonary resistance arteries and pulmonary arteries with good endothelial function.
CONCLUSION: Testosterone acts as an efficacious vasodilator in the human pulmonary vasculature, with dilatation observed at physiological concentrations in the male arterial resistance bed, dependent on the presence of an intact endothelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535892     DOI: 10.1007/BF03346526

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo.

Authors:  T M Chou; K Sudhir; S J Hutchison; E Ko; T M Amidon; P Collins; K Chatterjee
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

2.  Gender-specific inhibition of Ca2+ entry mechanisms of arterial vasoconstriction by sex hormones.

Authors:  J K Crews; R A Khalil
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-09       Impact factor: 2.557

3.  Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension.

Authors:  P A Woodmansey; L O'Toole; K S Channer; A H Morice
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

4.  Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action.

Authors:  Richard D Jones; Kate M English; Peter J Pugh; Alyn H Morice; T Hugh Jones; Kevin S Channer
Journal:  J Cardiovasc Pharmacol       Date:  2002-06       Impact factor: 3.105

5.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

Review 6.  Primary pulmonary hypertension.

Authors:  James R Runo; James E Loyd
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

7.  The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

Authors:  Chris J Malkin; Peter J Pugh; Richard D Jones; Dheeraj Kapoor; Kevin S Channer; T Hugh Jones
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

Review 8.  Androgens and cardiovascular disease.

Authors:  Peter Y Liu; Alison K Death; David J Handelsman
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

9.  Testosterone relaxes rabbit coronary arteries and aorta.

Authors:  P Yue; K Chatterjee; C Beale; P A Poole-Wilson; P Collins
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

10.  Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone.

Authors:  J Hall; R D Jones; T H Jones; K S Channer; C Peers
Journal:  Endocrinology       Date:  2006-03-09       Impact factor: 4.736

View more
  23 in total

1.  Effects of substitutive therapy on right ventricular systolic and diastolic functions in patients with idiopathic hypogonadotropic hypogonadism.

Authors:  Y T Yaylali; G Fidan Yaylali; F Akin; I Susam; M Bastemir
Journal:  J Endocrinol Invest       Date:  2010-09-02       Impact factor: 4.256

2.  The vasodilatory effect of testosterone on renal afferent arterioles.

Authors:  Yan Lu; Yiling Fu; Ying Ge; Luis A Juncos; Jane F Reckelhoff; Ruisheng Liu
Journal:  Gend Med       Date:  2012-03-22

Review 3.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 4.  Sex differences in the pulmonary circulation: implications for pulmonary hypertension.

Authors:  Yvette N Martin; Christina M Pabelick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-07       Impact factor: 4.733

Review 5.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

6.  Hypotestosteronemia is an important factor for the development of hypertension: elevated blood pressure in orchidectomized conscious rats is reversed by different androgens.

Authors:  Mercedes Perusquía; Daniela Contreras; Nieves Herrera
Journal:  Endocrine       Date:  2019-06-15       Impact factor: 3.633

Review 7.  Role of Testosterone in the Treatment of Cardiovascular Disease.

Authors:  Carolyn M Webb; Peter Collins
Journal:  Eur Cardiol       Date:  2017-12

8.  Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent.

Authors:  Mercedes Perusquía; Clayton D Greenway; Lisa M Perkins; John N Stallone
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-05-06       Impact factor: 3.619

Review 9.  Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites.

Authors:  Mercedes Perusquía; John N Stallone
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-12       Impact factor: 4.733

10.  Testosterone-induced relaxation involves L-type and store-operated Ca2+ channels blockade, and PGE 2 in guinea pig airway smooth muscle.

Authors:  Mercedes Perusquía; Edgar Flores-Soto; Bettina Sommer; Elias Campuzano-González; Inocencio Martínez-Villa; Aldo I Martínez-Banderas; Luis M Montaño
Journal:  Pflugers Arch       Date:  2014-05-29       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.